Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010
about
The Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 StudyMethodological Challenges in Estimating Trends and Burden of Cardiovascular Disease in Sub-Saharan AfricaMolecular In Vivo Imaging Using a Noninvasive Cardiac-Specific MLC-2v Promoter Driven Dual-Gene Recombinant Lentivirus Monitoring SystemThe epidemiology of cardiovascular diseases in sub-Saharan Africa: the Global Burden of Diseases, Injuries and Risk Factors 2010 Study.Astragaloside attenuates myocardial injury in a rat model of acute myocardial infarction by upregulating hypoxia inducible factor‑1α and Notch1/Jagged1 signaling.Variations in ischemic heart disease burden by age, country, and income: the Global Burden of Diseases, Injuries, and Risk Factors 2010 studyComparison of mobile apps for the leading causes of death among different income zones: a review of the literature and app stores.Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 studyIschemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathwayThe -844 G>A PAI-1 polymorphism is associated with acute coronary syndrome in Mexican population.bFGF attenuates endoplasmic reticulum stress and mitochondrial injury on myocardial ischaemia/reperfusion via activation of PI3K/Akt/ERK1/2 pathway.Glycyrrhetinic acid protects H9c2 cells from oxygen glucose deprivation-induced injury through the PI3K/AKt signaling pathway.Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costsSalvianolic acid B induced upregulation of miR-30a protects cardiac myocytes from ischemia/reperfusion injury.Impact of level and patterns of alcohol drinking on coronary heart disease and stroke burden in Argentina.Tetranectin as a Potential Biomarker for Stable Coronary Artery Disease.Bone marrow-derived mesenchymal stem cells rescue injured H9c2 cells via transferring intact mitochondria through tunneling nanotubes in an in vitro simulated ischemia/reperfusion model.Burden of cardiovascular morbidity and mortality following humanitarian emergencies: a systematic literature review.In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography.MiR-499-5p protects cardiomyocytes against ischaemic injury via anti-apoptosis by targeting PDCD4.The Effects of Age, Period, and Cohort on Mortality from Ischemic Heart Disease in China.MicroRNA-21 protects against cardiac hypoxia/reoxygenation injury by inhibiting excessive autophagy in H9c2 cells via the Akt/mTOR pathway.Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.Ischaemic heart disease in the former Soviet Union 1990-2015 according to the Global Burden of Disease 2015 Study.Triptolide Attenuates Myocardial Ischemia/Reperfusion Injuries in Rats by Inducing the Activation of Nrf2/HO-1 Defense Pathway.Cardiac regeneration in model organisms.Myocardial infarct size measurement using geometric angle calculation.Schisandrin B Ameliorates Myocardial Ischemia/Reperfusion Injury Through Attenuation of Endoplasmic Reticulum Stress-Induced Apoptosis.Melatonin reduces PERK-eIF2α-ATF4-mediated endoplasmic reticulum stress during myocardial ischemia-reperfusion injury: role of RISK and SAFE pathways interaction.Economic impact assessment from the use of a mobile app for the self-management of heart diseases by patients with heart failure in a Spanish region.
P2860
Q22241915-3DCB27F3-74B8-4829-9B2A-3F4B29BA0C2CQ26772252-BF64105C-67D3-4470-8993-95949BB1F586Q27301843-3989CB4E-3D93-4C85-8864-39556D82EAA5Q33653463-151E8726-DEB8-4CEA-B353-5A3F8606EE2AQ33702447-D92E9C47-7956-4C13-AE8E-154918668C61Q33807894-4F5907B3-6AED-4B9E-A8AD-5186914A5DC4Q33966831-D52FB2A8-C363-4664-8057-43E8EBFD2126Q34272932-95988BE6-E55B-47EA-AC9C-821E63F13E82Q35009164-76C02438-B388-4AEA-8C0E-C733333326ACQ35151527-B4560253-4458-458B-81C6-B192E9B373DCQ35206515-0E637BC7-9930-4FB9-AFB2-B59CD1EEA897Q36074350-B9711DAB-AED3-4539-BEE9-2CADC1CEA10FQ36089475-BB709C28-C18A-4959-9CD0-A33198774F6CQ36120714-7568A8D9-A2D1-45A5-ACBF-1DA24A0581A3Q36304314-DC57ABAE-008F-4C15-9912-595FF590158BQ36333867-3DEBCB0F-6760-4AB7-BB49-692B405AA311Q36520325-732E9E08-2783-4AC6-980C-635C12C1ABDCQ36529560-16F34294-754F-474E-ADA2-579FE68F166CQ36788392-BEC3995C-D705-4287-96AE-B8B1454A68C9Q37392535-3D54B0E1-D406-4E94-90A2-F050216A3660Q37628768-CE2C0CE3-323A-4226-B953-89BB26621995Q37662887-6FA63459-3E57-47C3-A54F-2D0AEDA901B5Q38851422-1C2DB5C2-A908-4C0C-BB1B-6A2609A0ABB4Q40052409-97A88F65-84F0-420A-9717-FE328442095FQ40517218-8662DBCE-7CB5-455B-B313-40E6AD49F9F0Q41783661-C2F364E5-79B1-49DE-8C10-14741EB7ACECQ47433614-1E7F69A5-71DA-4595-AD4B-52A039FD2809Q48023034-1F4275C8-DC8A-4638-AC37-CDFA1B4C7021Q51335343-2B805BE2-7F4A-4B2E-85AE-4DA40D3819F2Q53510073-15F83A46-0572-4DAE-BD68-92209C726FD7
P2860
Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Assessing the global burden of ...... ischemic heart disease in 2010
@ast
Assessing the global burden of ...... ischemic heart disease in 2010
@en
type
label
Assessing the global burden of ...... ischemic heart disease in 2010
@ast
Assessing the global burden of ...... ischemic heart disease in 2010
@en
prefLabel
Assessing the global burden of ...... ischemic heart disease in 2010
@ast
Assessing the global burden of ...... ischemic heart disease in 2010
@en
P2093
P2860
P50
P1433
P1476
Assessing the global burden of ...... ischemic heart disease in 2010
@en
P2093
Abraham D Flaxman
Andrew E Moran
Gregory Roth
Mohammad H Forouzanfar
P2860
P304
P356
10.1016/J.GHEART.2012.10.003
P577
2012-12-05T00:00:00Z